InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,576.98
(
0.07%
)
US TECH 100
19,916.80
(
0.12%
)
Dow Jones
39,291.97
(
-0.13%
)
Brent Oil
84.59
(
-0.97%
)
Bitcoin
58,019.45
(
2.32%
)
Post# of 463849
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

georgejjl

Send PM Follow Ignore
Followers 139
Posts 23282
Boards Moderated 0
Alias Born 04/08/2004

georgejjl

Re: Investor2014 post# 362055

Wednesday, 06/01/2022 6:45:33 PM

Wednesday, June 01, 2022 6:45:33 PM

Post# of 463849
Tanya is not a typical participant in a ANAVEX's Blarcamesine trial. Tanya is 41 years old and has had 3 decades of deteriorization from Rett syndrome. Tanya was titrated to the maximum dose for the Rett syndrome AVATAR trial, then she contracted a COVID infection and needed to go into the hospital to treat the COVID infection for 3 weeks (she had a severe COVID infection) then a couple of months later she had pneumonia. They believe that she had/has long COVID.

According to trial protocol she needed to start titration after the AVATAR trial (7 weeks) was completed, when she started the OLE trial. This was after she contracted COVID. Her COVID infection had/has understandably adversely affected her tolerability to Blarcamesine during the OLE trial.

GOD bless,
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News
InvestorsHub NewsWire

Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM

Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM

Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM

EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM

BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM

NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM

Start posting your company's news
Only $200 per official company press release!